Subscribe to RSS
DOI: 10.1055/s-2005-865199
A Novel and Convenient Synthesis of 3-(Polyhaloacyl)chromones Using Diethoxymethyl Acetate
Publication History
Publication Date:
14 April 2005 (online)
![](https://www.thieme-connect.de/media/synlett/200507/lookinside/thumbnails/10.1055-s-2005-865199-1.jpg)
Abstract
The reaction of 2-hydroxy-2-(polyhaloalkyl)chroman-4-ones with diethoxymethyl acetate readily occurs at 140-150 °C for 15 minutes to give 3-(polyhaloacyl)chromones in good yields.
Key words
chroman-4-ones - diethoxymethyl acetate - formylation - 3-(polyhaloacyl)chromones
-
1a
Ghosh CK. J. Heterocycl. Chem. 1983, 20: 1437 -
1b
Sabitha G. Aldrichimica Acta 1996, 29: 15 - 2
Eiden F.Haverland H. Arch. Pharm. 1967, 300: 806 - 3
Széll T.Eiden F. Arch. Pharm. 1972, 305: 81 -
4a
Becket GJP.Ellis GP. Tetrahedron Lett. 1976, 719 -
4b
Ghosh CK.Bhattacharya A. Indian J. Chem. Sect. B: Org. Chem. Incl. Med. Chem. 1984, 23: 668 -
5a
Nohara A.Umetani T.Sanno Y. Tetrahedron Lett. 1973, 1995 -
5b
Nohara A.Umetani T.Sanno Y. Tetrahedron 1974, 30: 3553 - 6
Sosnovskikh VYa. Russ. Chem. Rev. 2003, 72: 489 - 7
Yokoe I.Maruyama K.Sugita Y.Harashida T.Shirataki Y. Chem. Pharm. Bull. 1994, 42: 1697 -
8a
Borrell JI.Teixidó J.Schuler E.Michelotti E. Tetrahedron Lett. 2001, 42: 5331 -
8b
Gadhwal S.Sandhu JS. J. Chem. Soc., Perkin Trans. 1 2000, 2827 -
8c
Bandyopadhyay C.Sur KR.Patra R.Sen A. Tetrahedron 2000, 56: 3583 -
8d
Sandulache A.Silva AMS.Cavaleiro JAS. Tetrahedron 2002, 58: 105 -
8e
Singh G.Singh G.Ishar MPS. Synlett 2003, 256 -
8f
Singh G.Singh L.Ishar MPS. Tetrahedron 2002, 58: 7883 -
8g
Stankovicova H.Lacova M.Gaplovsky A.Chovancova J.Pronayova N. Tetrahedron 2001, 57: 3455 -
8h
Kaye PT.Nchinda AT.Sabbagh LV.Bacsa J. J. Chem. Res., Synop. 2003, 111 -
8i
Ryabukhin SV.Plaskon AS.Volochnyuk DM.Tolmachev AA. Synlett 2004, 2287 - 9
Gelin S.Chantegrel B.Nadi AI. J. Org. Chem. 1983, 48: 4078 -
10a
Montgomery JA.Holum LB. J. Am. Chem. Soc. 1958, 80: 404 -
10b
Montgomery JA.Temple C. J. Am. Chem. Soc. 1958, 80: 409 -
10c
Cushman M.Mavandadi F.Kugelbrey K.Bacher A. Bioorg. Med. Chem. 1998, 6: 409 -
10d
Akahoshi F.Takeda S.Okada T.Kajii M.Nishimura H.Sugiura M.Inoue Y.Fukaya C.Naito Y.Imagawa T.Nakamura N. J. Med. Chem. 1998, 41: 2985 -
11a
Morera E.Ortar G. Tetrahedron Lett. 1981, 22: 1273 -
11b
Sosnovskikh VYa.Sizov AYu.Usachev BI. Russ. Chem. Bull., Int. Ed. 2002, 51: 1270 -
11c
Sosnovskikh VYa.Usachev BI. Synthesis 2002, 1007 -
12a
Morita Y.Kamakura R.Takeda M.Yamamoto Y. Chem. Commun. 1997, 359 -
12b
Sosnovskikh VYa.Usachev BI.Sizov AYu. Russ. Chem. Bull., Int. Ed. 2002, 51: 2109 -
12c
Sosnovskikh VYa.Usachev BI.Bogdanov EA. Russ. Chem. Bull., Int. Ed. 2001, 50: 568
References
General Procedure for the Synthesis of Chromones 2.
A solution of chromanone 1 (1 mmol) in diethoxymethyl acetate (1.0 g, 6 mmol) was heated at 140-150 °C for 15-20 min. After cooling, the resulting mixture was diluted with hexane (3 mL). The solid product obtained on standing was collected by filtration, washed with hexane, and dried. Spectral and analytical data for selected products follows.
3-(Difluoroacetyl)-4
H
-chromen-4-one(2a) and 3-(2,2-difluoro-1,1-dihydroxyethyl)-4
H
-chromen-4-one (
3a): IR (KBr): 3076, 1711, 1654, 1614, 1560 cm-1. 1H NMR (400 MHz, CDCl3/TMS): 2a (99%) δ = 6.97 (t, 1 H, CF2H, 2
J
H,F = 53.3 Hz), 7.54 (t, 1 H, H-6, o
J = 7.6 Hz), 7.57 (d, 1 H, H-8, o
J = 8.4 Hz), 7.79 (ddd, 1 H, H-7, o
J = 8.6, 7.2 Hz, m
J = 1.6 Hz), 8.30 (dd, 1 H, H-5, o
J = 8.0 Hz, m
J = 1.6 Hz), 8.68 (s, 1 H, H-2); 3a (1%) δ = 5.47 (s, 2 H, 2 OH), 5.78 (t, 1 H, CF2H, 2
J
H,F = 56.1 Hz), 8.35 (s, 1 H, H-2). 19F NMR (376 MHz, CDCl3/C6F6): 2a (98%) δ = 30.81 (d, HCF2, 2
J
F,H = 53.3 Hz); 3a (2%) δ = 28.72 (d, HCF2, 2
J
F,H = 56.1 Hz). 13C NMR (100 MHz, CDCl3): 2a δ = 109.03 (t, CF2, 1 J
C,F = 247.6 Hz), 118.45, 120.25, 124.74, 126.50, 126.97, 135.10, 155.84, 162.85, 174.42, 186.51 (t, COCF2, 2
J
C,F = 25.6 Hz). Anal. Calcd for C11H6F2O3: C, 58.94; H, 2.70. Found: C, 58.96; H, 2.67.
3-(Trifluoroacetyl)-4
H
-chromen-4-one(2c) and 3-(2,2,2-trifluoro-1,1-dihydroxyethyl)-4
H
-chromen-4-one (
3c): 1H NMR (400 MHz, CDCl3/TMS): 2c (50%) δ = 7.50-7.58 (m, 2 H, H-6, H-8), 7.79 (ddd, 1 H, H-7, o
J = 8.6, 7.0 Hz, m
J = 1.7 Hz), 8.30 (dd, 1 H, H-5, o
J = 8.0 Hz, m
J = 1.7 Hz), 8.62 (s, 1 H, H-2); 3c (50%) δ = 6.06 (s, 2 H, 2 OH), 7.50-7.58 (m, 2 H, H-6, H-8), 7.78 (ddd, 1 H, H-7, o
J = 8.6, 7.0 Hz, m
J = 1.7 Hz), 8.26 (dd, 1 H, H-5, o
J = 8.0 Hz, m
J = 1.7 Hz), 8.40 (s, 1 H, H-2). 19F NMR (376 MHz, CDCl3/C6F6): 2c (50%) δ = 86.93 (s, CF3); 3c (50%) δ = 74.85 (s, CF3). Anal. Calcd for C11H5F3O3·0.25H2O: C, 53.56; H, 2.25. Found: C, 53.56; H, 2.29.
6-Methyl-3-(trifluoroacetyl)-4
H
-chromen-4-one(2d) and 3-(2,2,2-trifluoro-1,1-dihydroxyethyl)-4
H
-chromen-4-one (
3d): IR (KBr): 3309, 3059, 1718, 1664, 1635, 1601, 1558 cm-1. 1H NMR (400 MHz, CDCl3/TMS): 2d (70%) δ = 2.49 (s, 3 H, Me), 7.44 (d, 1 H, H-8, o
J = 8.6 Hz), 7.57 (ddq, 1 H, H-7, o
J = 8.6 Hz, m
J = 2.0 Hz, 4
J
H,CH3 = 0.6 Hz), 8.07 (dq, 1 H, H-5, m
J = 2.0 Hz, 4
J
H,CH3 = 0.6 Hz), 8.59 (s, 1 H, H-2); 3d (30%) δ = 2.49 (s, 3 H, Me), 6.16 (s, 2 H, 2 OH), 7.45 (d, 1 H, H-8, o
J = 8.6 Hz), 7.59 (ddq, 1 H, H-7, o
J = 8.6 Hz, m
J = 2.0 Hz, 4
J
H,CH3 = 0.6 Hz), 8.02 (dq, 1H, H-5, m
J = 2.0 Hz, 4
J
H,CH3 = 0.6 Hz), 8.37 (s, 1 H, H-2). Anal. Calcd for C12H7F3O3: C, 56.26; H, 2.75. Found: C, 55.98; H, 2.78.
3-(2,2,3,3-Tetrafluoropropanoyl)-4
H
-chromen-4-one(2g) and 3-(2,2,3,3-tetrafluoro-1,1-dihydroxypropyl)-4
H
-chromen-4-one (
3g): 1H NMR (400 MHz, CDCl3/TMS): 2g (94%) δ = 6.80 (tt, 1 H, CF2CF2H, 2
J
H,F = 53.3 Hz, 3
J
H,F = 5.8 Hz), 7.54 (ddd, 1 H, H-6, o
J = 8.0, 7.2 Hz, m
J = 1.0 Hz), 7.57 (ddd, 1 H, H-8, o
J = 8.5 Hz, m
J = 1.0 Hz, p
J = 0.4 Hz), 7.79 (ddd, 1 H, H-7, o
J = 8.6, 7.2 Hz, m
J = 1.7 Hz), 8.27 (ddd, 1 H, H-5, o
J = 8.0 Hz, m
J = 1.7 Hz, p
J = 0.4 Hz), 8.55 (s, 1 H, H-2); 3g (6%) δ = 6.28 (tt, 1 H, CF2CF2H, 2
J
H,F = 53.2 Hz, 3
J
H,F = 6.2 Hz), 6.31 (s, 2 H, 2 OH), 7.51 (ddd, 1 H, H-6, o
J = 8.0, 7.2 Hz, m
J = 1.0 Hz), 7.57 (dd, 1 H, H-8, o
J = 8.5 Hz, m
J = 1.0 Hz), 8.23 (dd, 1 H, H-5, o
J = 8.0 Hz, m
J = 1.7 Hz), 8.37 (s, 1 H, H-2). 19F NMR (376 MHz, CDCl3/C6F6): 2g (90%) δ = 24.06 (dt, HCF
2
CF2, 2
J
H,F = 53.3 Hz, 3
J
F,F = 7.3 Hz), 38.73 (td, HCF2
CF
2
, 3
J
F,F = 7.3 Hz, 3
J
F,H = 5.8 Hz); 3g (10%) δ = 25.39 (dt, HCF
2
CF2, 2
J
F,H = 53.1 Hz, 3
J
F,F = 7.7 Hz), 30.78 (q, HCF2
CF
2
, 3
J
F,F = 3
J
F,H = 7.0 Hz). 13C NMR (100 MHz, CDCl3): 2g δ = 109.07 (tt, CF2, 1
J
C,F = 252.0 Hz, 2
J
C,F = 30.5 Hz), 110.54 (tt, CF2, 1
J
C,F = 262.1 Hz, 2
J
C,F = 27.4 Hz), 118.40, 120.85, 124.61, 126.39, 127.03, 135.17, 155.69, 162.30 (t, C-2, 5
J
C,F = 2.2 Hz), 173.69, 185.58 (t, COCF2, 2
J
C,F = 29.3 Hz). Anal. Calcd for C12H6F4O3: C, 52.57; H, 2.21. Found: C, 52.46; H, 2.24.